Insider filing · DNTH
Marino Garcia
CEO AND PRESIDENT
profile →
Dianthus Therapeutics, Inc.
DNTH · Healthcare · 18 filings in 24 months
ticker →
Marino Garcia sold $17.9M of Dianthus Therapeutics (DNTH)
Executed Aug 7, disclosed Aug 7, the same day.
Value, as filed
$17.9M
165,200 sh across 6 lots
Executed
Aug 7
the trade date, as filed
Disclosed
Aug 7
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MGMarino Garcia (CEO AND PRESIDENT) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Dianthus Therapeutics, Inc. (DNTH). The largest single filing was $17.9M of DNTH (165,200 sh across 6 lots, as filed), executed Aug 7.
The name
DNTHHealthcare · Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoi…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Marino Garcia in DNTH
DNTHSALE
Dianthus Therapeutics, Inc.
$9.9M121,818 sh across 3 lots
Exec Mar 12
Filed Mar 13 · 5:30 PM ET